Biomarkers in neuroendocrine tumors

Massimiliano Berretta, Alessandro Cappellani, Maria Di Vita, Salvatore Berretta, Guglielmo Nasti, Alessandra Bearz, Umberto Tirelli, Vincenzo Canzonieri

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Here we review the role of clinical biomarkers (tissue and circulating markers) in the management of neuroendocrine tumors. These tumors may originate in different organs, from cells embriologically different but expressing common phenotypic characteristics, such as the immuno-reactivity for markers of neuroendocrine differentiation (defined as "pan-neuroendocrine"), the capacity to secrete specific or aspecific peptide and hormones, and the expression of some receptors, that are at the basis of the current diagnostic and therapeutic approach.

Original languageEnglish
Pages (from-to)332-342
Number of pages11
JournalFrontiers in Bioscience - Scholar
Volume2 S
Issue number1
Publication statusPublished - Jan 1 2010

Fingerprint

Neuroendocrine Tumors
Peptide Hormones
Differentiation Antigens
Biomarkers
Tumors
Neoplasms
Tissue
Therapeutics

Keywords

  • Cancer
  • Clinical Biomarkers
  • Diagnosis
  • Neuroendocrine tumors
  • Review

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Biomarkers in neuroendocrine tumors. / Berretta, Massimiliano; Cappellani, Alessandro; Di Vita, Maria; Berretta, Salvatore; Nasti, Guglielmo; Bearz, Alessandra; Tirelli, Umberto; Canzonieri, Vincenzo.

In: Frontiers in Bioscience - Scholar, Vol. 2 S, No. 1, 01.01.2010, p. 332-342.

Research output: Contribution to journalArticle

Berretta, M, Cappellani, A, Di Vita, M, Berretta, S, Nasti, G, Bearz, A, Tirelli, U & Canzonieri, V 2010, 'Biomarkers in neuroendocrine tumors', Frontiers in Bioscience - Scholar, vol. 2 S, no. 1, pp. 332-342.
Berretta M, Cappellani A, Di Vita M, Berretta S, Nasti G, Bearz A et al. Biomarkers in neuroendocrine tumors. Frontiers in Bioscience - Scholar. 2010 Jan 1;2 S(1):332-342.
Berretta, Massimiliano ; Cappellani, Alessandro ; Di Vita, Maria ; Berretta, Salvatore ; Nasti, Guglielmo ; Bearz, Alessandra ; Tirelli, Umberto ; Canzonieri, Vincenzo. / Biomarkers in neuroendocrine tumors. In: Frontiers in Bioscience - Scholar. 2010 ; Vol. 2 S, No. 1. pp. 332-342.
@article{a0808666cfea441180b48b7c94844f54,
title = "Biomarkers in neuroendocrine tumors",
abstract = "Here we review the role of clinical biomarkers (tissue and circulating markers) in the management of neuroendocrine tumors. These tumors may originate in different organs, from cells embriologically different but expressing common phenotypic characteristics, such as the immuno-reactivity for markers of neuroendocrine differentiation (defined as {"}pan-neuroendocrine{"}), the capacity to secrete specific or aspecific peptide and hormones, and the expression of some receptors, that are at the basis of the current diagnostic and therapeutic approach.",
keywords = "Cancer, Clinical Biomarkers, Diagnosis, Neuroendocrine tumors, Review",
author = "Massimiliano Berretta and Alessandro Cappellani and {Di Vita}, Maria and Salvatore Berretta and Guglielmo Nasti and Alessandra Bearz and Umberto Tirelli and Vincenzo Canzonieri",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "2 S",
pages = "332--342",
journal = "Frontiers in Bioscience - Scholar",
issn = "1945-0516",
publisher = "Frontiers in Bioscience",
number = "1",

}

TY - JOUR

T1 - Biomarkers in neuroendocrine tumors

AU - Berretta, Massimiliano

AU - Cappellani, Alessandro

AU - Di Vita, Maria

AU - Berretta, Salvatore

AU - Nasti, Guglielmo

AU - Bearz, Alessandra

AU - Tirelli, Umberto

AU - Canzonieri, Vincenzo

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Here we review the role of clinical biomarkers (tissue and circulating markers) in the management of neuroendocrine tumors. These tumors may originate in different organs, from cells embriologically different but expressing common phenotypic characteristics, such as the immuno-reactivity for markers of neuroendocrine differentiation (defined as "pan-neuroendocrine"), the capacity to secrete specific or aspecific peptide and hormones, and the expression of some receptors, that are at the basis of the current diagnostic and therapeutic approach.

AB - Here we review the role of clinical biomarkers (tissue and circulating markers) in the management of neuroendocrine tumors. These tumors may originate in different organs, from cells embriologically different but expressing common phenotypic characteristics, such as the immuno-reactivity for markers of neuroendocrine differentiation (defined as "pan-neuroendocrine"), the capacity to secrete specific or aspecific peptide and hormones, and the expression of some receptors, that are at the basis of the current diagnostic and therapeutic approach.

KW - Cancer

KW - Clinical Biomarkers

KW - Diagnosis

KW - Neuroendocrine tumors

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=77957293966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957293966&partnerID=8YFLogxK

M3 - Article

VL - 2 S

SP - 332

EP - 342

JO - Frontiers in Bioscience - Scholar

JF - Frontiers in Bioscience - Scholar

SN - 1945-0516

IS - 1

ER -